These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 36160905)
1. HuR affects chemoresistance of small cell lung cancer by regulating FGFRL1 expression. Duan XH; Chen R; Li DS; Luo AH; Guo LL Exp Ther Med; 2022 Oct; 24(4):638. PubMed ID: 36160905 [TBL] [Abstract][Full Text] [Related]
2. FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K/Akt pathway via ENO1. Chen R; Li D; Zheng M; Chen B; Wei T; Wang Y; Li M; Huang W; Tong Q; Wang Q; Zhu Y; Fang W; Guo L; Fang S J Cell Mol Med; 2020 Feb; 24(3):2123-2134. PubMed ID: 31957179 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100. Xiao F; Bai Y; Chen Z; Li Y; Luo L; Huang J; Yang J; Liao H; Guo L Eur J Cancer; 2014 May; 50(8):1541-54. PubMed ID: 24559685 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA-HOTAIR affects chemoresistance by regulating HOXA1 methylation in small cell lung cancer cells. Fang S; Gao H; Tong Y; Yang J; Tang R; Niu Y; Li M; Guo L Lab Invest; 2016 Jan; 96(1):60-8. PubMed ID: 26707824 [TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway. Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270 [TBL] [Abstract][Full Text] [Related]
6. Identification of key genes and pathway related to chemoresistance of small cell lung cancer through an integrative bioinformatics analysis. Zeng FR; Zhou XY; Zeng LG; Sun JC; He F; Mo W; Wen Y; Wang SY; Liu Q; Guo LL Ann Transl Med; 2022 Sep; 10(18):968. PubMed ID: 36267705 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway. Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of secretagogin inhibits cell apoptosis and induces chemoresistance in small cell lung cancer under the regulation of miR-494. Bai Y; Sun Y; Peng J; Liao H; Gao H; Guo Y; Guo L Oncotarget; 2014 Sep; 5(17):7760-75. PubMed ID: 25226615 [TBL] [Abstract][Full Text] [Related]
9. CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter. Qiu Z; Zhu W; Meng H; Tong L; Li X; Luo P; Yi L; Zhang X; Guo L; Wei T; Zhang J Theranostics; 2019; 9(16):4717-4729. PubMed ID: 31367252 [No Abstract] [Full Text] [Related]
10. HOTAIR contributes to chemoresistance by activating NF-κB signaling in small-cell lung cancer. Chen R; Chen B; Li D; Wang Q; Zhu Y; Li M; Wang Y; Fang S; Guo L Int J Clin Exp Pathol; 2019; 12(8):2997-3004. PubMed ID: 31934137 [TBL] [Abstract][Full Text] [Related]
11. KCNQ1OT1 lncRNA affects the proliferation, apoptosis, and chemoresistance of small cell lung cancer cells via the JAK2/STAT3 axis. Zhu Y; Shen Y; Chen R; Li H; Wu Y; Zhang F; Huang W; Guo L; Chen Q; Liu H Ann Transl Med; 2021 May; 9(10):891. PubMed ID: 34164525 [TBL] [Abstract][Full Text] [Related]
12. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling. Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408 [TBL] [Abstract][Full Text] [Related]
13. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway. Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199 [TBL] [Abstract][Full Text] [Related]
14. [Role of SPHK1 regulates multi-drug resistance of small cell lung cancer and its clinical significance]. Yang L; Hu H; Deng Y; Bai Y Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):769-77. PubMed ID: 25404266 [TBL] [Abstract][Full Text] [Related]
15. Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer. Yu J; Wang S; Zhao W; Duan J; Wang Z; Chen H; Tian Y; Wang D; Zhao J; An T; Bai H; Wu M; Wang J Clin Cancer Res; 2018 May; 24(9):2148-2158. PubMed ID: 29437792 [No Abstract] [Full Text] [Related]
16. The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells. Blanco FF; Jimbo M; Wulfkuhle J; Gallagher I; Deng J; Enyenihi L; Meisner-Kober N; Londin E; Rigoutsos I; Sawicki JA; Risbud MV; Witkiewicz AK; McCue PA; Jiang W; Rui H; Yeo CJ; Petricoin E; Winter JM; Brody JR Oncogene; 2016 May; 35(19):2529-41. PubMed ID: 26387536 [TBL] [Abstract][Full Text] [Related]
17. miR-210 promotes human osteosarcoma cell migration and invasion by targeting FGFRL1. Liu X; Zhang C; Wang C; Sun J; Wang D; Zhao Y; Xu X Oncol Lett; 2018 Aug; 16(2):2229-2236. PubMed ID: 30008923 [TBL] [Abstract][Full Text] [Related]
18. H3K27me3 induces multidrug resistance in small cell lung cancer by affecting HOXA1 DNA methylation via regulation of the lncRNA HOTAIR. Fang S; Shen Y; Chen B; Wu Y; Jia L; Li Y; Zhu Y; Yan Y; Li M; Chen R; Guo L; Chen X; Chen Q Ann Transl Med; 2018 Nov; 6(22):440. PubMed ID: 30596070 [TBL] [Abstract][Full Text] [Related]
19. The Role of RNA-Binding Protein HuR in Lung Cancer by RNA Sequencing Analysis. Ye X; Fu Q; Xiao H Front Genet; 2022; 13():813268. PubMed ID: 35450220 [No Abstract] [Full Text] [Related]
20. [Overexpression of fibroblast growth factor receptor like 1 (FGFRL1) inhibits proliferation and migration of HCT116 human colon cancer cells, and promotes their apoptosis]. Guan L; Dong Y; Chen S; Wang C; Feng L; Xie Y; Tang X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Mar; 38(3):251-256. PubMed ID: 35365991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]